Table 2.
Multivariate Analysis of Risk Factors for Mortality
| Risk Factor | OR | 95% CI for OR | P Value | |
|---|---|---|---|---|
| Lower | Upper | |||
| Demographics | ||||
| Age, y | 1.12 | 1.01 | 1.25 | .037 |
| Sex (female vs male) | 0.32 | 0.04 | 2.41 | .270 |
| Vital signs | ||||
| SpO2, % | 0.97 | 0.86 | 1.09 | .565 |
| Heart rate, beats/min | 1.00 | 0.96 | 1.04 | .977 |
| Respiratory rate, breaths/min | 1.13 | 0.94 | 1.35 | .181 |
| Consciousness disorders (disorders vs clear) | 1.38 | 0.08 | 24.00 | .827 |
| Histories | ||||
| Hypertension (yes vs no) | 0.82 | 0.24 | 2.75 | .744 |
| Previous respiratory diseases (yes vs no) | 3.24 | 0.45 | 23.57 | .245 |
| Laboratory values | ||||
| WBC count, ×109/L | 1.28 | 1.00 | 1.64 | .052 |
| LYM count, ×109/L | 0.01 | 0.00 | 0.14 | .001 |
| NT‐proBNP, ×102 pg/mL | 1.00 | 1.00 | 1.00 | .514 |
| PCT, ng/mL | 0.96 | 0.73 | 1.27 | .791 |
| hs‐TnI, pg/mL | 1.03 | 1.00 | 1.07 | .065 |
| D‐dimer, μg/mL FEU | 1.07 | 0.95 | 1.22 | .278 |
| ALT, U/L | 0.98 | 0.94 | 1.02 | .231 |
| AST, U/L | 1.04 | 0.99 | 1.09 | .137 |
| Creatinine, μmol/L | 1.04 | 0.96 | 1.13 | .340 |
| eGFR, mL/min/1.73 m2 | 1.04 | 0.92 | 1.16 | .543 |
| hs‐CRP, mg/L | 1.01 | 1.00 | 1.02 | .122 |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval; eGFR, estimated glomerular filtration rate; hs‐CRP, high‐sensitivity C‐reactive protein; hs‐TnI, high‐sensitivity cardiac troponin I; LYM, lymphocyte; NT‐proBNP, amino‐terminal pro‐brain natriuretic peptide; OR, odds ratio; PCT, procalcitonin; SpO2, oxygen saturation; WBC, white blood cell; FEU, fibrinogen equivalent units.